# Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

> **NCT00471705** · PHASE3 · COMPLETED · sponsor: **Universidad de Antioquia** · enrollment: 437 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Miltefosine
- **DEVICE:** Thermotherapy
- **DRUG:** Glucantime®

## Key facts

- **NCT ID:** NCT00471705
- **Lead sponsor:** Universidad de Antioquia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-08
- **Final completion:** 2009-12
- **Target enrollment:** 437 (ACTUAL)
- **Last updated:** 2019-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471705, "Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00471705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*